RE: Very sorry26 Mar 2020 19:34
The long term is very good with a unique and growing family of procedures and patents plus the future turbine blade project. The short term is pretty disastrous with, I suspect, falling revenue streams.
We are a sitting duck for a take-over and at this price, even with say a 50% uplift, a lot of minor shareholders will indeed pretty much be wiped out. What a sad end for some of us who have been here for many years, in my case almost 14. I sincerely hope we can weather this but it's a pretty tricky situation.